Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tislelizumab can cause cutaneous lupus erythematosus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Anti-CD19 therapy may help treat SLE and NMOSD.

CS12192 effectively treats alopecia areata with better safety than current options.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Enhancing Tregs can protect against alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.